The Mineralocorticoid Receptor as a Novel Player in Skin Biology: Beyond the Renal Horizon?

    November 2009 in “ Experimental Dermatology
    Nicolette Farman, Eve Maubec, Burkhard Poeggeler, Jennifer E. Klatte, Frederic Jaisser, Ralf Paus
    Image of study
    TLDR The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.
    The document explores the role of the mineralocorticoid receptor (MR) in skin and hair biology, traditionally associated with kidney function and cardiovascular health. It reviews evidence from mouse models and human observations indicating that MR is expressed in the skin and may contribute to skin and hair disorders, including alopecia. The paper suggests that MR could be a target for therapeutic intervention, particularly in the context of the side effects of corticosteroid treatments in dermatology. It also discusses the use of MR antagonists like spironolactone and eplerenone in treating cardiovascular conditions and proposes their potential application in treating skin atrophy and hair loss. The document calls for further research to understand the role of MR in skin physiology and its involvement in conditions like androgenic alopecia, as well as the pharmacokinetics of MR antagonists in the skin for both local and systemic administration.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    4 / 4 results

      community When someone posts a scalp tension theory

      in Satire  265 upvotes 3 years ago
      Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Group Buy for MR antagonist finerenone

      in Product  11 upvotes 1 year ago
      User discusses group buy for finerenone, a third-gen mineralocorticoid antagonist for hair loss treatment. Finerenone inhibits TGFb, NOX, and ROS, and improves renal and cardiac function; topical dose should be no more than 10mg per day.

    Similar Research

    5 / 401 results